Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

We describe two cases of patients with hepatitis C virus (HCV) treated with direct-acting antiviral (DAA) therapy who had dramatic improvement in hepatocellular carcinoma (HCC) tumor burden with DAA therapy alone. Both patients were diagnosed with HCC on screening magnetic resonance imaging shortly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Hepatocell Carcinoma
Autors principals: Griffith, Anna S, Hayashi, Paul H, Burke, Lauren MB, McRee, Autumn J
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Case Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5987785/
https://ncbi.nlm.nih.gov/pubmed/29911076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S152569
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars